Evidence map›Paper›PMID 25702638›Full record

ArticleStem cell reports2015

The L1TD1 protein interactome reveals the importance of post-transcriptional regulation in human pluripotency.

Maheswara Reddy Emani, Elisa Närvä, Aki Stubb, Deepankar Chakroborty, Miro Viitala, Anne Rokka, Nelly Rahkonen, Robert Moulder, Konstantin Denessiouk, Ras Trokovic and 3 more

Open access · goldAbstract read
In one paragraph

Article in Stem cell reports, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 25 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
25citing papers in PubMed, 1 pooled it
0.9field-weighted citation impact, top 26% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

25 citing papers in PubMed, 1 synthesis or guideline pooled it, 45 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Comprehensive Profiling of NAdvanced science (Weinheim, Baden-Wurttemberg, Germany) · 2026
    Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. AP-1 activity is a major barrier of human somatic cell reprogramming.Cellular and molecular life sciences : CMLS · 2021
    Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors at 4 institutions in 1 country.

Maheswara Reddy EmaniTurku Centre for Biotechnology, University of Turku and Åbo Akademi University, 20521 Turku, Finland.
Elisa NärväTurku Centre for Biotechnology, University of Turku and Åbo Akademi University, 20521 Turku, Finland.
Aki StubbTurku Centre for Biotechnology, University of Turku and Åbo Akademi University, 20521 Turku, Finland.
Deepankar ChakrobortyTurku Centre for Biotechnology, University of Turku and Åbo Akademi University, 20521 Turku, Finland.
Miro ViitalaTurku Centre for Biotechnology, University of Turku and Åbo Akademi University, 20521 Turku, Finland.
Anne RokkaTurku Centre for Biotechnology, University of Turku and Åbo Akademi University, 20521 Turku, Finland.
Nelly RahkonenTurku Centre for Biotechnology, University of Turku and Åbo Akademi University, 20521 Turku, Finland.
Robert MoulderTurku Centre for Biotechnology, University of Turku and Åbo Akademi University, 20521 Turku, Finland.
Konstantin DenessioukTurku Centre for Biotechnology, University of Turku and Åbo Akademi University, 20521 Turku, Finland.
Ras TrokovicResearch Programs Unit, Molecular Neurology and Biomedicum Stem Cell Center, University of Helsinki, 00290 Helsinki, Finland.
Riikka LundTurku Centre for Biotechnology, University of Turku and Åbo Akademi University, 20521 Turku, Finland.
Laura L EloTurku Centre for Biotechnology, University of Turku and Åbo Akademi University, 20521 Turku, Finland; Department of Mathematics and Statistics, University of Turku, 20014 Turku, Finland.
Riitta LahesmaaTurku Centre for Biotechnology, University of Turku and Åbo Akademi University, 20521 Turku, Finland. Electronic address: riitta.lahesmaa@btk.fi.
Åbo Akademi University · FIUniversity of Turku · FITurku Centre for Biotechnology · FIUniversity of Helsinki · FI

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The RNA-binding protein L1TD1 is one of the most specific and abundant proteins in pluripotent stem cells and is essential for the maintenance of pluripotency in human cells. Here, we identify the protein interaction network of L1TD1 in human embryonic stem cells (hESCs) and provide insights into the interactome network constructed in human pluripotent cells. Our data reveal that L1TD1 has an important role in RNA splicing, translation, protein traffic, and degradation. L1TD1 interacts with multiple stem-cell-specific proteins, many of which are still uncharacterized in the context of development. Further, we show that L1TD1 is a part of the pluripotency interactome network of OCT4, SOX2, and NANOG, bridging nuclear and cytoplasmic regulation and highlighting the importance of RNA biology in pluripotency.

Indexed as

Gene Expression RegulationProtein Interaction MappingRNA Processing, Post-TranscriptionalAmino Acid SequenceCarrier ProteinsCell NucleusCell Self RenewalCytoplasmHumansMolecular Sequence DataPluripotent Stem CellsProteasome InhibitorsProtein BindingProtein Interaction Domains and MotifsProtein Interaction MapsProteinsCarrier ProteinsL1TD1 protein, humanProteasome InhibitorsProteinsRNA-Binding Proteins

Identifiers

PMID25702638
PMCPMC4376047
OpenAlexW2090984301

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.